164 related articles for article (PubMed ID: 6378594)
1. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
Ryan MP; Peavy DE; Frank BH; Duckworth WC
Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
[TBL] [Abstract][Full Text] [Related]
2. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
Peavy DE; Abram JD; Frank BH; Duckworth WC
Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
[TBL] [Abstract][Full Text] [Related]
3. High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease.
Hamel FG; Peavy DE; Ryan MP; Duckworth WC
Endocrinology; 1986 Jan; 118(1):328-33. PubMed ID: 3510119
[TBL] [Abstract][Full Text] [Related]
4. Degradation of the four monoiodoinsulin isomers by the insulin protease of rat liver.
Brush JS; Sonne O; Gliemann J
Biochim Biophys Acta; 1983 Jun; 757(3):269-73. PubMed ID: 6342683
[TBL] [Abstract][Full Text] [Related]
5. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
Sonne O; Linde S; Larsen TR; Gliemann J
Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
[TBL] [Abstract][Full Text] [Related]
6. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
Linde S; Sonne O; Hansen B; Gliemann J
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):573-9. PubMed ID: 7024083
[TBL] [Abstract][Full Text] [Related]
7. Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies.
Diaz JL; Wilkin TJ
Clin Chem; 1988 Feb; 34(2):356-9. PubMed ID: 2449302
[TBL] [Abstract][Full Text] [Related]
8. Conversion of biosynthetic human proinsulin to partially cleaved intermediates by collagenase proteinases adsorbed to isolated rat adipocytes.
Duckworth WC; Peavy DE; Hamel FG; Liepnieks J; Brunner MR; Heiney RE; Frank BH
Biochem J; 1988 Oct; 255(1):277-84. PubMed ID: 2848505
[TBL] [Abstract][Full Text] [Related]
9. [Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera].
Zhou W; Li S; Deng S
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):369-72. PubMed ID: 8150434
[TBL] [Abstract][Full Text] [Related]
10. Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytes.
Duckworth WC; Hamel FG; Liepnieks JJ; Peavy DE; Ryan MP; Hermodson MA; Frank BH
Biochem Biophys Res Commun; 1987 Sep; 147(2):615-21. PubMed ID: 3307783
[TBL] [Abstract][Full Text] [Related]
11. High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line.
Duckworth WC; Hamel FG; Liepnieks J; Frank BH; Yagil C; Rabkin R
Endocrinology; 1988 Dec; 123(6):2701-8. PubMed ID: 3058457
[TBL] [Abstract][Full Text] [Related]
12. Drosophila insulin degrading enzyme and rat skeletal muscle insulin protease cleave insulin at similar sites.
Duckworth WC; Garcia JV; Liepnieks JJ; Hamel FG; Hermodson MA; Frank BH; Rosner MR
Biochemistry; 1989 Mar; 28(6):2471-7. PubMed ID: 2659071
[TBL] [Abstract][Full Text] [Related]
13. Developing rat brain binds monoiodinated insulin isomers similarly to other extrahepatic target tissues.
Kappy MS; Clarke DW; Raizada MK; Boyd FT; Frank BH
Brain Res; 1985 Dec; 360(1-2):195-202. PubMed ID: 3907754
[TBL] [Abstract][Full Text] [Related]
14. Evidence for separate handling in vivo of different regions of the insulin molecule using A14- and B1-labeled insulin tracers.
Cockram CS; Jones RH; Boroujerdi MA; Sönksen PH
Diabetes; 1984 Aug; 33(8):721-7. PubMed ID: 6378697
[TBL] [Abstract][Full Text] [Related]
15. Identification of insulin intermediates and sites of cleavage of native insulin by insulin protease from human fibroblasts.
Stentz FB; Kitabchi AE; Schilling JW; Schronk LR; Seyer JM
J Biol Chem; 1989 Dec; 264(34):20275-82. PubMed ID: 2684974
[TBL] [Abstract][Full Text] [Related]
16. [125I]diiodoinsulins. Binding affinities, biologic potencies, and properties of their decay products.
Pérez Maceda B; Linde S; Sonne O; Gliemann J
Diabetes; 1982 Jul; 31(7):634-40. PubMed ID: 7160541
[TBL] [Abstract][Full Text] [Related]
17. Degradation of insulin by isolated rat renal cortical endosomes.
Fawcett J; Rabkin R
Endocrinology; 1993 Oct; 133(4):1539-47. PubMed ID: 8404592
[TBL] [Abstract][Full Text] [Related]
18. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
Misbin RI; Almira EC
Diabetes; 1989 Feb; 38(2):152-8. PubMed ID: 2644137
[TBL] [Abstract][Full Text] [Related]
19. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
Sato H; Tsuji A; Hirai K; Kang YS
Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
[TBL] [Abstract][Full Text] [Related]
20. Degradation products of insulin generated by hepatocytes and by insulin protease.
Duckworth WC; Hamel FG; Peavy DE; Liepnieks JJ; Ryan MP; Hermodson MA; Frank BH
J Biol Chem; 1988 Feb; 263(4):1826-33. PubMed ID: 3276679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
